Literature DB >> 15655776

Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection.

Hiroshi Kimura1, Yo Hoshino, Shinya Hara, Naomi Sugaya, Jun-Ichi Kawada, Yukiko Shibata, Seiji Kojima, Tetsuro Nagasaka, Kiyotaka Kuzushima, Tsuneo Morishima.   

Abstract

Infections of T cells and natural killer (NK) cells play a central role in the pathogenesis of chronic active Epstein-Barr virus (CAEBV) infection. To characterize the virologic and cytokine profiles of T cell-type and NK cell-type infection, 39 patients with CAEBV infection were analyzed. Patients with T cell-type infection had higher titers of immunoglobulin G against early and late EBV antigens, suggesting lytic cycle infection. However, the pattern of EBV gene expression was latency type II; BZLF1, which is a hallmark of lytic cycle infection, could not be detected in any patients, regardless of infection type. Patients with CAEBV infection had high concentrations of proinflammatory, T helper cell type 1, and anti-inflammatory cytokines. The cytokine profile in patients with NK cell-type infection was similar to that in patients with T cell-type infection, but the concentration of IL-13 was high in patients with NK cell-type infection. These findings should help to clarify the pathogenesis of CAEBV infection and facilitate the development of more-effective treatments.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15655776     DOI: 10.1086/427239

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  35 in total

1.  Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States.

Authors:  Jeffrey I Cohen; Elaine S Jaffe; Janet K Dale; Stefania Pittaluga; Helen E Heslop; Cliona M Rooney; Stephen Gottschalk; Catherine M Bollard; V Koneti Rao; Adriana Marques; Peter D Burbelo; Siu-Ping Turk; Rachael Fulton; Alan S Wayne; Richard F Little; Mitchell S Cairo; Nader K El-Mallawany; Daniel Fowler; Claude Sportes; Michael R Bishop; Wyndham Wilson; Stephen E Straus
Journal:  Blood       Date:  2011-03-31       Impact factor: 22.113

2.  Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008.

Authors:  J I Cohen; H Kimura; S Nakamura; Y-H Ko; E S Jaffe
Journal:  Ann Oncol       Date:  2009-06-10       Impact factor: 32.976

3.  Clonal expansion of Epstein-Barr virus (EBV)-infected γδ T cells in patients with chronic active EBV disease and hydroa vacciniforme-like eruptions.

Authors:  Taizo Wada; Akiko Toga; Yasuhisa Sakakibara; Tomoko Toma; Minoru Hasegawa; Kazuhiko Takehara; Tomonari Shigemura; Kazunaga Agematsu; Akihiro Yachie
Journal:  Int J Hematol       Date:  2012-08-12       Impact factor: 2.490

4.  Epstein-Barr virus associated T-cell lymphoproliferative disease misdiagnosed as ulcerative colitis: a case report.

Authors:  Xiaodan Zheng; Jianlan Xie; Xiaoge Zhou
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

5.  Optimal treatment for chronic active Epstein-Barr virus disease.

Authors:  Jeffrey I Cohen
Journal:  Pediatr Transplant       Date:  2009-06

6.  Adhesion of Epstein-Barr virus-positive natural killer cell lines to cultured endothelial cells stimulated with inflammatory cytokines.

Authors:  H Kanno; D Watabe; N Shimizu; T Sawai
Journal:  Clin Exp Immunol       Date:  2008-01-08       Impact factor: 4.330

Review 7.  The Epstein-Barr Virus (EBV) in T Cell and NK Cell Lymphomas: Time for a Reassessment.

Authors:  A A Gru; B H Haverkos; A G Freud; J Hastings; N B Nowacki; C Barrionuevo; C E Vigil; R Rochford; Y Natkunam; R A Baiocchi; P Porcu
Journal:  Curr Hematol Malig Rep       Date:  2015-12       Impact factor: 3.952

8.  Flow cytometric analysis of skin blister fluid induced by mosquito bites in a patient with chronic active Epstein-Barr virus infection.

Authors:  Taizo Wada; Tadafumi Yokoyama; Hiroyasu Nakagawa; Erika Asai; Akiko Toga; Yasuhisa Sakakibara; Fumie Shibata; Yumi Tone; Masaki Shimizu; Tomoko Toma; Akihiro Yachie
Journal:  Int J Hematol       Date:  2009-11-14       Impact factor: 2.490

9.  An adult case of systemic Epstein-Barr virus-positive T/natural killer-cell lymphoproliferative disorder with good outcome.

Authors:  Xiuming Zhang; Zhaoming Wang; Lijun Wang; Hongtian Yao
Journal:  Int J Clin Exp Pathol       Date:  2013-10-15

10.  EBV Zta protein induces the expression of interleukin-13, promoting the proliferation of EBV-infected B cells and lymphoblastoid cell lines.

Authors:  Shu-Chun Tsai; Sue-Jane Lin; Po-Wen Chen; Wen-Yi Luo; Te-Huei Yeh; Hsei-Wei Wang; Chi-Ju Chen; Ching-Hwa Tsai
Journal:  Blood       Date:  2009-05-05       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.